An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies.

C. Merola, C. Albarracin, Philip W. Lebowitz, R. S. Bienkowski, S. M. Barst

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

We examined records of sedations provided by the paediatric anaesthesiology staff for 455 children (ages 1 mo-17 yr) undergoing MRI or CT scans at our institution over a twelve-month period with regard to the monitoring of adverse events: excessive sedation, agitation, vomiting, hypoxaemia, and major airway compromise. One hundred-and-thirty-one patients (29%) received chloral hydrate; 324 patients (71%) received propofol. All patients were monitored with continuous noninvasive pulse oximetry and received supplemental oxygen via nasal cannulae. Of the patients who received chloral hydrate, 64 (49%) were over one year of age; of the patients who received propofol, 318 (98%) were one year of age or older. In the chloral hydrate group, 23 patients (19%) were deemed excessively sedated and four patients (3%) were agitated; no patients in the propofol group experienced any of the adverse outcomes reviewed. Furthermore, no patients in either group had significant airway compromise and none was admitted to the hospital as a result of the sedation.

Original languageEnglish (US)
Pages (from-to)375-378
Number of pages4
JournalPaediatric Anaesthesia
Volume5
Issue number6
StatePublished - 1995

Fingerprint

Chloral Hydrate
Propofol
Oximetry
Anesthesiology
Vomiting
Pediatrics
Oxygen

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Merola, C., Albarracin, C., Lebowitz, P. W., Bienkowski, R. S., & Barst, S. M. (1995). An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies. Paediatric Anaesthesia, 5(6), 375-378.

An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies. / Merola, C.; Albarracin, C.; Lebowitz, Philip W.; Bienkowski, R. S.; Barst, S. M.

In: Paediatric Anaesthesia, Vol. 5, No. 6, 1995, p. 375-378.

Research output: Contribution to journalArticle

Merola, C, Albarracin, C, Lebowitz, PW, Bienkowski, RS & Barst, SM 1995, 'An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies.', Paediatric Anaesthesia, vol. 5, no. 6, pp. 375-378.
Merola, C. ; Albarracin, C. ; Lebowitz, Philip W. ; Bienkowski, R. S. ; Barst, S. M. / An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies. In: Paediatric Anaesthesia. 1995 ; Vol. 5, No. 6. pp. 375-378.
@article{1bd0a10b7cde4240bbfb66463e4e9385,
title = "An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies.",
abstract = "We examined records of sedations provided by the paediatric anaesthesiology staff for 455 children (ages 1 mo-17 yr) undergoing MRI or CT scans at our institution over a twelve-month period with regard to the monitoring of adverse events: excessive sedation, agitation, vomiting, hypoxaemia, and major airway compromise. One hundred-and-thirty-one patients (29{\%}) received chloral hydrate; 324 patients (71{\%}) received propofol. All patients were monitored with continuous noninvasive pulse oximetry and received supplemental oxygen via nasal cannulae. Of the patients who received chloral hydrate, 64 (49{\%}) were over one year of age; of the patients who received propofol, 318 (98{\%}) were one year of age or older. In the chloral hydrate group, 23 patients (19{\%}) were deemed excessively sedated and four patients (3{\%}) were agitated; no patients in the propofol group experienced any of the adverse outcomes reviewed. Furthermore, no patients in either group had significant airway compromise and none was admitted to the hospital as a result of the sedation.",
author = "C. Merola and C. Albarracin and Lebowitz, {Philip W.} and Bienkowski, {R. S.} and Barst, {S. M.}",
year = "1995",
language = "English (US)",
volume = "5",
pages = "375--378",
journal = "Paediatric Anaesthesia",
issn = "1155-5645",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - An audit of adverse events in children sedated with chloral hydrate or propofol during imaging studies.

AU - Merola, C.

AU - Albarracin, C.

AU - Lebowitz, Philip W.

AU - Bienkowski, R. S.

AU - Barst, S. M.

PY - 1995

Y1 - 1995

N2 - We examined records of sedations provided by the paediatric anaesthesiology staff for 455 children (ages 1 mo-17 yr) undergoing MRI or CT scans at our institution over a twelve-month period with regard to the monitoring of adverse events: excessive sedation, agitation, vomiting, hypoxaemia, and major airway compromise. One hundred-and-thirty-one patients (29%) received chloral hydrate; 324 patients (71%) received propofol. All patients were monitored with continuous noninvasive pulse oximetry and received supplemental oxygen via nasal cannulae. Of the patients who received chloral hydrate, 64 (49%) were over one year of age; of the patients who received propofol, 318 (98%) were one year of age or older. In the chloral hydrate group, 23 patients (19%) were deemed excessively sedated and four patients (3%) were agitated; no patients in the propofol group experienced any of the adverse outcomes reviewed. Furthermore, no patients in either group had significant airway compromise and none was admitted to the hospital as a result of the sedation.

AB - We examined records of sedations provided by the paediatric anaesthesiology staff for 455 children (ages 1 mo-17 yr) undergoing MRI or CT scans at our institution over a twelve-month period with regard to the monitoring of adverse events: excessive sedation, agitation, vomiting, hypoxaemia, and major airway compromise. One hundred-and-thirty-one patients (29%) received chloral hydrate; 324 patients (71%) received propofol. All patients were monitored with continuous noninvasive pulse oximetry and received supplemental oxygen via nasal cannulae. Of the patients who received chloral hydrate, 64 (49%) were over one year of age; of the patients who received propofol, 318 (98%) were one year of age or older. In the chloral hydrate group, 23 patients (19%) were deemed excessively sedated and four patients (3%) were agitated; no patients in the propofol group experienced any of the adverse outcomes reviewed. Furthermore, no patients in either group had significant airway compromise and none was admitted to the hospital as a result of the sedation.

UR - http://www.scopus.com/inward/record.url?scp=0029442167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029442167&partnerID=8YFLogxK

M3 - Article

C2 - 8597970

AN - SCOPUS:0029442167

VL - 5

SP - 375

EP - 378

JO - Paediatric Anaesthesia

JF - Paediatric Anaesthesia

SN - 1155-5645

IS - 6

ER -